Table 4.
Postoperative complication and histological diagnosis
| CDT (%) | CM (%) | NT-BTD (%) | T-BTD (%) | NIFTP (%) | P value | ||
|---|---|---|---|---|---|---|---|
| Bleeding | Day 1 | 3.4 | 0.0 | 2.0 | 15.8 | 0.0 | 0.014 |
| Parestesia | Day 1 | 8.4 | 0.0 | 4.0 | 16.4 | 0.0 | 0.001 |
| Day 7 | 2.2 | 0.0 | 1.3 | 0.0 | 0.0 | 0.856 | |
| Day 30 | 1.9 | 0.0 | 0.8 | 0.0 | 0.0 | 0.936 | |
| 6 Months | 0.3 | 0.0 | 0.5 | 0.0 | 0.0 | 0.991 | |
| Dysphonia | Day 1 | 4.3 | 0.0 | 5.3 | 10.5 | 0.0 | 0.717 |
| Day 7 | 4.7 | 0.0 | 4.4 | 0.0 | 0.0 | 0.867 | |
| Day 30 | 3.1 | 0.0 | 4.4 | 0.0 | 0.0 | 0.951 | |
| 6 Month | 1.3 | 0.0 | 2.1 | 0.0 | 0.0 | 0.877 | |
| Dysphnea | Day 7 | 0.9 | 0.0 | 0.5 | 5.9 | 0.0 | 0.555 |
| Day 30 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.862 | |
| 6 Month | 0.3 | 0.0 | 0.5 | 0.0 | 0.0 | 0.990 |
CDT differentiated thyroid carcinoma, CM medullary carcinoma, NT-BTD non-toxic benign thyroid disease, T-BTD toxic benign thyroid disease, NIFTP non-invasive follicular thyroid neoplasm with papillary-like nuclear features